Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1982-06-29
1985-02-05
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
424116, 435169, A61K 3500, C12P 106
Patent
active
044977972
ABSTRACT:
.beta.-Galactosidase inhibitors GT-2558, GT-2558-A, and GT-2558-B produced by a strain Streptomyces lydicus PA-5726, and their derivatives, acetyl-GT-2558-A and acetyl-GT-2558-B, useful as diagnostatic aid in .beta.-galactosidase deficiency, used in purification of enzymes, in research of new .beta.-galactosidase, in controlling sweetness of lactose-containing foods and in fermentation industry.
REFERENCES:
patent: 3978210 (1976-08-01), Mizuno et al.
patent: 3991183 (1976-11-01), Celmer et al.
Ebata Mitsuo
Kawamura Yoshimi
Miyake Yukio
Goldberg Jerome D.
Shionogi & Co. Ltd.
LandOfFree
.beta.-Galactosidase inhibitor GT-2558 and its derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .beta.-Galactosidase inhibitor GT-2558 and its derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .beta.-Galactosidase inhibitor GT-2558 and its derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2082449